Bithionol是一种抗寄生虫药物，对若干癌细胞有抑制作用。

Bithionol, formerly marketed as an active ingredient in various topical drug products, was shown to be a potent photosensitizer with the potential to cause serious skin disorders. Approvals of the NDA's for bithionol drug products were withdrawn on October 24, 1967.

Ovarian cancer cell lines (5 × 103 cells/well) were plated into 96-well flat bottom plates (Corning, Inc., Corning, NY) and incubated for overnight. Cells were treated with different concentrations of BT ranging from 0.178 μM to 400 μM and further incubated for 48 hrs or 72 hrs. (Only for Reference)

97-18-7

C12H6Cl4O2S

356.04

硫氯酚;硫双二氯酚;Actamer

DMSO:66 mg/mL (185.4 mM)
Ethanol:21 mg/mL (59 mM)
H2O:<1 mgml
Powder: -20°C for 3 years
In solvent: -80°C for 2 years